Axonics Modulation Technologies Stock Fundamentals
Axonics Modulation Technologies fundamentals help investors to digest information that contributes to Axonics Modulation's financial success or failures. It also enables traders to predict the movement of Axonics Stock. The fundamental analysis module provides a way to measure Axonics Modulation's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Axonics Modulation stock.
Axonics |
Axonics Modulation Technologies Company Current Valuation Analysis
Axonics Modulation's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Axonics Modulation Current Valuation | 3.32 B |
Most of Axonics Modulation's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Axonics Modulation Technologies is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
CompetitionIn accordance with the recently published financial statements, Axonics Modulation Technologies has a Current Valuation of 3.32 B. This is 76.92% lower than that of the Health Care Equipment & Supplies sector and 73.32% lower than that of the Health Care industry. The current valuation for all United States stocks is 80.06% higher than that of the company.
Axonics Modulation Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Axonics Modulation's current stock value. Our valuation model uses many indicators to compare Axonics Modulation value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Axonics Modulation competition to find correlations between indicators driving Axonics Modulation's intrinsic value. More Info.Axonics Modulation Technologies is rated below average in return on equity category among its peers. It also is rated below average in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Axonics Modulation's earnings, one of the primary drivers of an investment's value.Axonics Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Axonics Modulation's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Axonics Modulation could also be used in its relative valuation, which is a method of valuing Axonics Modulation by comparing valuation metrics of similar companies.Axonics Modulation is currently under evaluation in current valuation category among its peers.
Axonics Fundamentals
| Return On Equity | -0.0089 | |||
| Return On Asset | -0.0063 | |||
| Profit Margin | (0.01) % | |||
| Operating Margin | (0.02) % | |||
| Current Valuation | 3.32 B | |||
| Shares Outstanding | 51.11 M | |||
| Shares Owned By Insiders | 1.26 % | |||
| Shares Owned By Institutions | 87.22 % | |||
| Number Of Shares Shorted | 3.31 M | |||
| Price To Earning | (10.68) X | |||
| Price To Book | 5.46 X | |||
| Price To Sales | 8.40 X | |||
| Revenue | 366.38 M | |||
| Gross Profit | 197.66 M | |||
| EBITDA | 7.78 M | |||
| Net Income | (6.09 M) | |||
| Cash And Equivalents | 213.23 M | |||
| Cash Per Share | 4.53 X | |||
| Total Debt | 27.62 M | |||
| Debt To Equity | 0.02 % | |||
| Current Ratio | 10.49 X | |||
| Book Value Per Share | 13.00 X | |||
| Cash Flow From Operations | (2.02 M) | |||
| Short Ratio | 7.14 X | |||
| Earnings Per Share | (0.10) X | |||
| Price To Earnings To Growth | (0.56) X | |||
| Target Price | 72.0 | |||
| Number Of Employees | 797 | |||
| Beta | 0.83 | |||
| Market Capitalization | 3.63 B | |||
| Total Asset | 719.92 M | |||
| Retained Earnings | (380.35 M) | |||
| Working Capital | 445.61 M | |||
| Current Asset | 171.14 M | |||
| Current Liabilities | 12.98 M | |||
| Net Asset | 719.92 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Other Consideration for investing in Axonics Stock
If you are still planning to invest in Axonics Modulation check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Axonics Modulation's history and understand the potential risks before investing.
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon |